Thursday, 15 October 2026European Markets

EU Regulations

5 articles

Battery Industry Conferences Focus on Energy Transition Technologies

Battery Industry Conferences Focus on Energy Transition Technologies

The Battery Show Europe 2026 will convene industry leaders to address next-generation battery solutions and strategic partnerships shaping the energy transition. Industry conferences are positioning themselves as platforms for innovation and collaboration amid evolving regulatory and supply chain pressures.

LM Salvado•
EU Semiconductor Industry Faces Strategic Challenge as US-China AI Chip Controls Tighten

EU Semiconductor Industry Faces Strategic Challenge as US-China AI Chip Controls Tighten

The Trump administration is considering export permits for GPUs while Nvidia halts H200 chip production, creating uncertainty for European AI infrastructure. The regulatory crackdown on US-China hardware flows exposes Europe's dependency on external supply chains at a critical juncture for AI deployment. European chipmakers and data center operators must navigate intensifying geopolitical pressures without domestic alternatives to cutting-edge AI accelerators.

LM Salvado•
EU Accelerates AI Safety Rules After Pentagon Claude Ban and Gemini Lawsuit

EU Accelerates AI Safety Rules After Pentagon Claude Ban and Gemini Lawsuit

The European Commission is fast-tracking AI safety provisions within the EU AI Act following March 2026 incidents including the Pentagon's Claude AI ban and a lawsuit against Google's Gemini for suicide encouragement. Brussels is coordinating with the White House on potential Defense Production Act measures while pushing for international governance standards through the OECD AI Policy Observatory.

ViaNews Editorial Team (Europe)•
CyberArk's €15B merger faces EU antitrust review over cybersecurity market concentration

CyberArk's €15B merger faces EU antitrust review over cybersecurity market concentration

European Commission regulators are preparing to scrutinize the proposed CyberArk acquisition by Athens Strategies Ltd., citing concerns over market dominance in privileged access management software. The deal joins a growing list of cybersecurity mergers under regulatory review across Israeli, US, and EU jurisdictions. EU officials flag the sector's strategic importance to critical infrastructure protection.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com